Karyn E Yonekawa
Overview
Explore the profile of Karyn E Yonekawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaplan H, Goldstein S, Rubinson C, Daraiseh N, Zhang F, Rodgers I, et al.
Am J Med Qual
. 2023 Dec;
39(1):21-32.
PMID: 38127682
Context and implementation approaches can impede the spread of patient safety interventions. The objective of this article is to characterize factors associated with improved outcomes among 9 hospitals implementing a...
2.
Yonekawa K, Zhou C, Haaland W, Wright D
J Hosp Med
. 2019 Apr;
14(8):462-467.
PMID: 30986180
Background: In the hospitalized patient, nephrotoxin exposure is one potentially modifiable risk factor for acute kidney injury (AKI). Clinical decision support based on nephrotoxin ordering was developed at our hospital...
3.
Young G, Yonekawa K, Nakagawa P, Blain R, Lovejoy A, Nugent D
Blood Coagul Fibrinolysis
. 2007 Sep;
18(6):547-53.
PMID: 17762530
Bleeding is the major adverse reaction to anticoagulants, leading to significant morbidity and even mortality. Protamine is a specific antidote for heparin yet is only partially effective for enoxaparin, and...
4.
Young G, Yonekawa K, Nakagawa P, Blain R, Lovejoy A, Nugent D
Blood Coagul Fibrinolysis
. 2007 Feb;
18(2):97-103.
PMID: 17287624
New anticoagulants, including the direct thrombin inhibitors (DTIs) and fondaparinux, are increasingly replacing unfractionated heparin and enoxaparin. We examined the effects of argatroban (n = 60), bivalirudin (n = 44),...
5.
Young G, Yonekawa K, Nakagawa P, Nugent D
Perfusion
. 2004 Oct;
19(5):283-8.
PMID: 15506032
We investigated the anticoagulant effects of argatroban, a direct thrombin inhibitor, versus heparin in extracorporeal membrane oxygenation (ECMO) circuits. Three sham circuits were prepared according to our hospital's standard practice...